RespirAI Medical Receives Grant from Nebraska DED to Advance AI-Based COPD Monitoring

RespirAI Medical has been awarded a $100,000 Academic R&D Phase I Grant from the Nebraska Department of Economic Development (DED). The funding will support the continued development of the company’s AI-powered home monitoring platform for early detection of COPD exacerbations. This milestone marks a step forward toward clinical validation and FDA market approval, reinforcing RespirAI’s commitment to accessible, preventative care—particularly in underserved and rural communities.